224 related articles for article (PubMed ID: 30777857)
1.
Guerrero-Preston R; Lawson F; Rodriguez-Torres S; Noordhuis MG; Pirini F; Manuel L; Valle BL; Hadar T; Rivera B; Folawiyo O; Baez A; Marchionni L; Koch WM; Westra WH; Kim YJ; Eshleman JR; Sidransky D
Cancer Prev Res (Phila); 2019 Apr; 12(4):255-270. PubMed ID: 30777857
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes.
Lenze NR; Farquhar D; Sheth S; Zevallos JP; Blumberg J; Lumley C; Patel S; Hackman T; Weissler MC; Yarbrough WG; Zanation AM; Olshan AF
Laryngoscope; 2021 Jun; 131(6):1301-1309. PubMed ID: 33170518
[TBL] [Abstract][Full Text] [Related]
3. Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer.
Chaudhary S; Dam V; Ganguly K; Sharma S; Atri P; Chirravuri-Venkata R; Cox JL; Sayed Z; Jones DT; Ganti AK; Ghersi D; Macha MA; Batra SK
Cancer Lett; 2020 Nov; 492():44-53. PubMed ID: 32738272
[TBL] [Abstract][Full Text] [Related]
4. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
[TBL] [Abstract][Full Text] [Related]
5. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
6. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
[TBL] [Abstract][Full Text] [Related]
7. Explaining Racial Disparities in Surgically Treated Head and Neck Cancer.
Jassal JS; Cramer JD
Laryngoscope; 2021 May; 131(5):1053-1059. PubMed ID: 33107610
[TBL] [Abstract][Full Text] [Related]
8. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
Wu ES; Park JY; Zeitouni JA; Gomez CR; Reis IM; Zhao W; Kwon D; Lee E; Nelson OL; Lin HY; Franzmann EJ; Savell J; McCaffrey TV; Goodwin WJ; Hu JJ
Head Neck; 2016 Aug; 38(8):1234-41. PubMed ID: 27028310
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in patients with head and neck squamous cell carcinoma.
Gourin CG; Podolsky RH
Laryngoscope; 2006 Jul; 116(7):1093-106. PubMed ID: 16826042
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
11. Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities.
Schrank TP; Han Y; Weiss H; Resto VA
Head Neck; 2011 Jan; 33(1):45-53. PubMed ID: 20848419
[TBL] [Abstract][Full Text] [Related]
12. Establishment and validation of a tumor-infiltrating γδT cell related prognostic gene signature in head and neck squamous cell carcinoma.
Lu Y; Xiang Z; Wang W; Yun B; Yi C; Zhang M; Xie N; Wang C; Zhuang Z
Int Immunopharmacol; 2024 May; 132():112054. PubMed ID: 38608477
[TBL] [Abstract][Full Text] [Related]
13. A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.
Shi C; Liu S; Tian X; Wang X; Gao P
BMC Cancer; 2021 Sep; 21(1):1035. PubMed ID: 34530752
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival.
Ambatipudi S; Langdon R; Richmond RC; Suderman M; Koestler DC; Kelsey KT; Kazmi N; Penfold C; Ho KM; McArdle W; Ring SM; Pring M; Waterboer T; Pawlita M; Gaunt TR; Davey Smith G; Thomas S; Ness AR; Relton CL
Oral Oncol; 2018 Oct; 85():87-94. PubMed ID: 30220325
[TBL] [Abstract][Full Text] [Related]
15. Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center.
Zandberg DP; Liu S; Goloubeva O; Ord R; Strome SE; Suntharalingam M; Taylor R; Morales RE; Wolf JS; Zimrin A; Lubek JE; Schumaker LM; Cullen KJ
Head Neck; 2016 Apr; 38(4):564-72. PubMed ID: 25488341
[TBL] [Abstract][Full Text] [Related]
16. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract][Full Text] [Related]
17. Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals.
Fakhry C; Krapcho M; Eisele DW; D'Souza G
Cancer; 2018 May; 124(10):2125-2133. PubMed ID: 29533459
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
[TBL] [Abstract][Full Text] [Related]
19. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.
Guerrero-Preston R; Michailidi C; Marchionni L; Pickering CR; Frederick MJ; Myers JN; Yegnasubramanian S; Hadar T; Noordhuis MG; Zizkova V; Fertig E; Agrawal N; Westra W; Koch W; Califano J; Velculescu VE; Sidransky D
Epigenetics; 2014 Jul; 9(7):1031-46. PubMed ID: 24786473
[TBL] [Abstract][Full Text] [Related]
20. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
Chen Y; Li ZY; Zhou GQ; Sun Y
Clin Cancer Res; 2021 Jan; 27(1):330-341. PubMed ID: 33097495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
